Asian Spectator

Men's Weekly

.

American Express Opens New Centurion Lounge at Tokyo’s Haneda Airport

NEW YORK, US - Media OutReach Newswire - 15 July 2025 - On July 16 American Express (NYSE: AXP) will open a new Centurion Lounge at Tokyo's Haneda Airport (HND), the busiest airport in Japan and one ...

FUN! JAPAN Launched FUN! JAPAN-KIZUNA , an online bulletin board where visitors can ask locals for more in-depth Information about Japan!

Discover Japan's Hidden Treasures: Unveiling “FUN! JAPAN-KIZUNA” – The Gateway to In-Depth Insights through Local Interaction on online bulletin boardTOKYO, JAPAN - Media ...

VinSmart leader reveals the plan on bringing many flagship products to the US

HANOI, VIETNAM - Media OutReach - 2 December 2020 - VinSmart is planning to bring leading technology products, including the Vsmart Aris Pro -- one of the first mobiles with no-defect s...

China Tobacco Anhui Industry Corporation Announces Toop-One (D...

HEFEI, China, Jan. 29, 2019 /PRNewswire-AsiaNet/ -- China Tobacco Anhui Industry Corporation, a subsidiary of China National Tobacco Corporation, announces that a new MaPH product from the T...

Handheld unveils unique wearable SP500X ScanPrinter for logist...

LIDKÖPING, Sweden, Aug. 18, 2021 /PRNewswire-AsiaNet/ -- Handheld Group [https://www.handheldgroup.com/?utm_source=PRNewsWire&utm_medium=PressRelease&utm_campaign=SP500XLaunch]...

New CCVT.com Variety Show Invites Audience to Say Hello to Life

BEIJING, April 15, 2020 /PRNewswire-AsiaNet/ -- One-third of our time should be focused on enjoying life. "Say Hello to Life", a new variety show by CCTV.com, navigates the lives of young ad...

Community-based Social Innovation for Youth Program in Hong Kong Prize Presentation Ceremony for the Fourth Social Innovation • Community 4.0 Competition

HONG KONG SAR - Media OutReach - 15 July 2022- A team of four Form 3 students from HKSYCIA Wong Tai Shan Memorial College was crowned champion at this year’s “Social Innovatio...

Hospitality Disruptor Generator Acquires Freehand Hotels In Its Quest to Dominate the Experience Economy in U.S. Market

London-based Queensgate Investments finalizes $400 million purchase of Freehand Hotels from a seller consortium including The Yucaipa Companies and Sydell Group, drastically expanding Genera...

LONGi ranks again in BNEF Tier 1 list for Q1 2023 with its PV ...

XI'AN, China, March 21, 2023 /PRNewswire-Asianet/ -- LONGi, a world-leading solar technology company, has ranked once again in the list of photovoltaic (PV) module manufacturers meeting Bloo...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 5, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "eribulin") will be presented during the 42nd San Antonio Breast Cancer Symposium (SABCS2019). The symposium will be held from December 10 through 14, 2019, in San Antonio, Texas in the United States.

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

A total of five poster presentations will be given at this year's SABCS including the study results evaluating absolute lymphocyte count at the baseline with eribulin as a predictor of overall survival from the post-hoc analysis of two Phase III clinical studies of eribulin in patients with advanced or metastatic breast cancer.Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. Eisai will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.

Contact:Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Cara membuat prompt AI yang bagus biar produktif: tip dari ahli

FOTOSPLASH/Shutterstock“Apakah kamu mampu memanfaatkan AI dalam pekerjaan?”Kecerdasan buatan alias artificial intelligence (AI) sudah jadi bagian dari keseharian kita. Mulai dari ChatGPT, ...

Cara membahas masalah tanpa menimbulkan pertengkaran: Tip dari ahli

Pormezz / ShutterstockKita sebagai manusia memiliki perbedaan satu sama lain yang memengaruhi pendapat kita. Maka dari itu, ada kalanya kita tidak setuju dengan pendapat orang lain.Berbeda pendapat ka...

Diplomasi emosional: Bagaimana rasa marah dan takut dapat membentuk arah kebijakan global

Gambar Perdana Menteri Israel Benjamin Netanyahu (kiri) dan Pemimpin Tertinggi Iran Ayatollah Ali Khamenei di layar, merefleksikan perang antara Iran dan Israel.Mmiss.cabul/Shutterstock● Memanas...